إعلان
إعلان
AVIR
Atea Pharmaceuticals, Inc. Common Stock
3.46
USDبرعاية
-0.15
-4.24%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
3.46
0.00
+0.09%
تقارير أرباح AVIR
النسبة الإيجابية المفاجئة
AVIR تفوق 15 من 21 آخر التقديرات.
71%
التقرير التالي
بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.54
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+1.89%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+35.00%
Atea Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, AVIR reported earnings of -0.53 USD per share (EPS) for Q3 25, missing the estimate of -0.44 USD, resulting in a -18.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.54 USD, with revenue projected to reach -- USD, implying an زيادة of 1.89% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Atea Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Atea Pharmaceuticals, Inc. Common Stock reported EPS of -$0.53, missing estimates by -18.09%, and revenue of $0.00, 0% as expectations.
How did the market react to Atea Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -12.57%, changed from $3.50 before the earnings release to $3.06 the day after.
When is Atea Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
What are the forecasts for Atea Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 4
المحللين, Atea Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.54 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان